梅曼丁会在患者中加剧发作吗? 一个潜在的队列研究研究
Peiyu Wang1, Lu Lu1, Hui Gao1
1Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Annals of clinical and translational neurology
|November 25, 2025
概括
补充记忆素并没有使患者的发作恶化. 这项研究发现记忆素耐受性良好,与没有记忆素相比,具有类似的控制和不良事件. 需要进行进一步的试验.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种慢性神经系统疾病,其特点是经常性发作.
- 认知障碍在中很常见,记忆剂用于治疗认知缺陷.
- 人们对孟坦丁可能加剧患者的发作存在担忧.
研究的目的:
- 调查和认知障碍患者添加剂美曼丁的安全性.
- 为了评估梅曼丁是否会加剧发作或增加发作频率.
主要方法:
- 对211名患有和认知障碍的参与者进行前性队列研究.
- 参与者被跟踪至少24周.
- 在服用孟坦丁和不服用孟坦丁的人群中,比较了结局和不良事件.
主要成果:
- 在这两组中都没有观察到新的双边强力克隆性发作.
- 6%的参与者报告了发作频率 (≥25%) 的增加 (7名在记忆剂组,5名在非记忆剂组).
- 孟坦丁组报告了常见的不良事件,如头痛和头;24周保留率为91%.
结论:
- 辅助的孟坦因在患者中似乎能很好地耐受发作控制和不良事件.
- 之前关于时使用孟坦丁的安全担忧可能是不成比例的.
- 需要进行更大规模的随机试验来证实这些发现,并探索记忆素在的疗效.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
613
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
613
Antiepileptic Drugs: Glutamate Antagonists
865
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
865
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K


